Clinical Observation on 30 Cases of Hepatic Cirrhosis with Proteinuria Treated with Combination of Clearing, Purging, Resolving and Tonifying Method

Li Yongwei; Yang Hongzhi; Wang Yongze; et al.

doi:10.13288/j.11-2166/r.2004.12.017

您当前的位置：

首页 >

文章列表页 >

Clinical Observation on 30 Cases of Hepatic Cirrhosis with Proteinuria Treated with Combination of Clearing, Purging, Resolving and Tonifying Method

更新时间：2021-11-20

- Clinical Observation on 30 Cases of Hepatic Cirrhosis with Proteinuria Treated with Combination of Clearing, Purging, Resolving and Tonifying Method
- Journal of Traditional Chinese Medicine Issue 12, Pages: 911-913(2004)
- 作者机构：
  
  1. 中山大学附属第三医院中医科
  2. 江西省吉安市人民医院广州市天河路600号,510630
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2004.12.017
  CLC： R259
- Published：2004
- 稿件说明：
移动端阅览
[1]李永伟,杨宏志,王拥泽,关卫兵,杨跃武,刘小明.清下消补法治疗肝硬化合并蛋白尿30例临床观察[J].中医杂志,2004(12):911-913.

Li Yongwei, Yang Hongzhi, Wang Yongze, et al. Clinical Observation on 30 Cases of Hepatic Cirrhosis with Proteinuria Treated with Combination of Clearing, Purging, Resolving and Tonifying Method[J]. Journal of Traditional Chinese Medicine2004, (12): 911-913.
[1]李永伟,杨宏志,王拥泽,关卫兵,杨跃武,刘小明.清下消补法治疗肝硬化合并蛋白尿30例临床观察[J].中医杂志,2004(12):911-913. DOI： 10.13288/j.11-2166/r.2004.12.017.

Li Yongwei, Yang Hongzhi, Wang Yongze, et al. Clinical Observation on 30 Cases of Hepatic Cirrhosis with Proteinuria Treated with Combination of Clearing, Purging, Resolving and Tonifying Method[J]. Journal of Traditional Chinese Medicine2004, (12): 911-913. DOI： 10.13288/j.11-2166/r.2004.12.017.

摘要

目的:采用回顾性研究方法观察以中医清下消补法立方所组成的清下消补方合五子衍宗汤加减治疗肝硬化合并蛋白尿的疗效。方法:肝硬化失代偿期合并蛋白尿患者60例

治疗组30例

予清下消补方合五子衍宗汤加减治疗;对照组30例

用肾肝宁胶囊。两组均以相同的西药治疗

包括护肝支持及对症治疗

检查治疗前后血中的丙氨酸转氨酶（ALT）、总蛋白（TP）、白蛋白（ALB）、总胆红素（TBIL）、直接胆红素（DBIL）、尿素氮（BUN）、肌酐（SCr）和24小时尿蛋白定量（24hu-pro）

尿中的免疫球蛋白、白蛋白（IgGu、ALBu）。结果:两组治疗后组内各指标均有改善（P<0.05）

两组间ALT、SCr的改善无显著性差异（P>0.05）

治疗组TP、ALB、TBIL、DBIL、BUN和24hu-pro、IgGu、ALBu水平较对照组改善更明显（P<0.05）。结论:清下消补方合五子衍宗汤加减对肝硬化合并蛋白尿患者具有减轻蛋白尿、改善肾功能的疗效

为该类疾病的治疗提供了新的思路。

Abstract

Objective: To observe the clinical effect of modified combined Qingxia Xiaobu Prescription and Wuzi Yanzong Decoction on hepatic cirrhosis with proteinuria. Methods: 60 cases of hepatic cirrhosis with proteinuria at compensatory phase were divided into the treatment group（n=30） treated with modified Qingxia Xiaobu Priscription and Wuzi Yanzong Decoction

and the control group treated with Shenganning Capsules. And the patients of the two groups were all treated by the same western medicine including liver-aid

supporting and expectant treatment. The changes of blood glutamic-pyruvic transminase （ALT）

total protein （TP）

albumin （ALB）

total bilirubin （TBIL）

direct bilirubin （DBIL）

urea nitrogen （BUN）

creatinite （SCr） and 24-h-urinary protein （24hu-pro）

urinary immunoglobulin G（IgGu） and albumin （ALBu） levels before and after treatment were detected. Results: The all indexes in the two groups after treatment improved significantly （P<0. 05） and the treatment group had more significant improvement in TP

ALB

TBIL

DBIL

BUN and 24hu-pro

IgGu and ALBu levels as compared with the control group （P<0. 05）. Conclusion: The modified combined Qingxia Xiaobu Description and Wuzi Yanzong Decoction can alleviate urinary protein and improve renal function in the patient of hepatic cirrhosis with proteinuria.

关键词

Keywords

references

查看原文

Views

102

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Efficacy and Economic Evaluation of 1293 Non-Severe Adult Patients with Community-Acquired Pneumonia Treated by the Jiangsu Traditional Chinese Medicine Diagnosis and Treatment Protocol for Dominant Diseases：A Multicenter，Retrospective Real-World Cohort Study

Exploring the Comorbidity Mechanism，Prevention and Treatment Strategies of Rheumatoid Arthritis with Coronary Atherosclerotic Heart Disease Based on Collateral Disease Theory

Syndrome Differentiation and Treatment of Cholinergic Urticaria from the Perspective of "Treating Fire Constraint by Dispersing It"

The Philosophy and Practical Pathway of "Dao （道）-Shen （神）-Formula" in Traditional Chinese Medicine

Differentiation and Treatment of Small Cell Lung Cancer from the Perspective of "Internal Wind in Hidden Circulation"

Related Author

No data

Related Institution

No data

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰